Pfizer (PFE) Tops Q3 EPS by 29c, Raises FY Guidance

Pfizer (NYSE: PFE) reported Q3 EPS of $1.37, $0.29 better than the analyst estimate of $1.08. Revenue for the quarter came in at $24.1 billion versus the consensus estimate of $22.68 billion.

GUIDANCE:

Pfizer sees 2021 EPS of $4.13-$4.18 (previously $3.95 to $4.05). Pfizer sees 2021 revenue of $81-82 billion (previously $78.0 to $80.0 billion).

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• 374Water Inc (SCWO) Misses Q2 EPS by 15c
• Nvidia and Broadcom earnings: TD Cowen says earnings won’t settle big questions